CVS: Overdone on the sell side following a mega news announcement by Wal Mart entry to pharmacy business. Mispricing created here as price declines are too oversold and pending recovery with support around 30 level followed by 28. Look for recovery in a solid Large Cap name – looking for bearish expectation to moderated and recover from extremes.
Also, given the defensive theme of this stock – looking for stability around current trading range.
Valuation seems positive: (good investment entry point)
The trailing p/e is a very reasonable 19.95 (imho), with a forward p/e of 16.57 (as estimated for fye 31-Dec-07). With quick growth estimated, the stock appears to be an excellent value with a PEG (5 yr expected) estimated at 0.62.
No comments:
Post a Comment